Immunological memory is the ability of our immune system to respond with greater strength and quickness upon re-encounter with the same pathogen (i.e. secondary infection). Immunological memory is the basis for vaccination which remains the most successful method for preventing infectious disease. Yet, a fully protective vaccine that prevents a single human parasitic disease has not been realized to date. Why is immunity to parasitic pathogens so difficulty to achieve? Our current work on secondary infections with the apicomplexan parasite, Toxoplasma gondii, suggest that failure of immunological memory responses is genetically determined. In this grant submission, we have used a forward genetic approach to uncover new requirements for host immunity to highly virulent strains T. gondii. Both genetic and immunological data converge on a B-1b cell population that is specifically expanded in resistant mice. This cell type represents a bridge between innate and adaptive immune immunity, which can recognize both self- and foreign- antigen. Our central hypothesis is that memory B-1 cells control resistance to challenge with virulent T. gondii strains, and this response is determined by allelic variation of Nfkbid. I?BNS, encoded by Nfkbid, is a member of the atypical nuclear regulators of NF-?B-dependent transcription. Nfkbid null mice fail to develop B-1 cells and antibody responses to T-independent antigens, and as reported here, have massive defects in producing T. gondii-specific antibodies. Experimental approaches from immunology, genetics and molecular parasitology will be used to address questions surrounding our central hypothesis.
In Aim 1, adoptive transfer experiments will be performed to delineate protection conferred by the B-1 lineage and the functional quality of parasite-specific antibodies they produce.
In Aim 2, epigenetic approaches are proposed to study the mechanism by which I?BNS mediates protective B cell responses during a secondary infection.
In Aim 3, we will explore whether antibody responses directed against GPI-moieties on T. gondii surface antigens explain parasite strain-differences in secondary infection virulence. Antigenic variation is the major mechanism by which protozoan pathogens such as African Trypanosomes, Plasmodium sp. and Giardia evade B cell- mediated antibody responses. Surface antigens of T. gondii are highly polymorphic. Immunity conferred by B-1 cells may depend on their ability to produce antibodies that recognize broadly conserved epitopes within variable surface antigens. Eliciting this response during vaccination could have major bearing on the prevention of human parasitic disease.
Parasitic disease inflicts great morbidity worldwide, yet there is only one partially protective vaccine currently in use for malaria prevention. Our genetic analysis as to why immunological memory responses fail against virulent strains of the parasite Toxoplasma gondii, has led us to study a unique population of B cells that we hypothesize plays a major role in host protection. By studying this immune cell, how it behaves and what triggers its activation, better vaccines that promote immunity to parasitic pathogens may be achieved.
